CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹3.72 Cr | ₹2.82 Cr | ₹1.96 Cr | ₹2.30 Cr | ₹1.87 Cr |
What is the latest Long Term Provisions ratio of CONCORD BIOTECH ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹3.72 Cr |
| Mar2025 | ₹2.82 Cr |
| Mar2024 | ₹1.96 Cr |
| Mar2023 | ₹2.30 Cr |
| Mar2022 | ₹1.87 Cr |
How is Long Term Provisions of CONCORD BIOTECH Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹3.72 Cr | 31.91 | |
| Mar2025 | ₹2.82 Cr | 44.17 | |
| Mar2024 | ₹1.96 Cr | -14.85 | |
| Mar2023 | ₹2.30 Cr | 22.57 | |
| Mar2022 | ₹1.87 Cr | - | |
Compare Long Term Provisions of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,640.9 Cr | 1.6% | -1.7% | -25.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 1.6% |
-1.7% |
-25.5% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses